2-Amino-5-chloro-3H-pyrimido[4,5-b]indol-4(9H)-one

Catalog No. :
ACKSDG078
CAS No. :
1126602-45-6
Molecular Formula :
C10H7ClN4O
Molecular Weight :
234.65

IUPAC Name:2-amino-5-chloro-3,9-dihydro-4H-pyrimido[4,5-b]indol-4-one

2-Amino-5-chloro-3H-pyrimido[4,5-b]indol-4(9H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$417.00Login to see priceInquiryInquiry
100mg95%$613.00Login to see priceInquiryInquiry
250mg95%$866.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-5-chloro-3H-pyrimido[4,5-b]indol-4(9H)-one
IUPAC Name2-amino-5-chloro-3,9-dihydro-4H-pyrimido[4,5-b]indol-4-one
MDL No.-
Molecular FormulaC10H7ClN4O
Molecular Weight234.65
SMILESO=C1NC(N)=NC(N2)=C1C3=C2C=CC=C3Cl
InChI KeyBCEATAARWXWOBC-UHFFFAOYSA-N
Synonym2-AMINO-5-CHLORO-3H-PYRIMIDO[4,5-B]INDOL-4(9H)-ONE;2-Amino-5-chloro-3,9-dihydro-4H-pyrimido[4,5-b]indol-4-one;2-amino-5-chloro-3H,4H,9H-pyrimido[4,5-b]indol-4-one;4H-Pyrimido[4,5-b]indol-4-one, 2-amino-5-chloro-3,9-dihydro-
CAS No.1126602-45-6
PubChem CID135741886

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H317
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACKSDG078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  4. Plus
  5. ACHFAI786 route compound structure diagram
    ACHFAI78629671-92-9 In Stock
  6. Then
  7. ACKSDG078 route product structure diagram
    ACKSDG0781126602-45-6
Inquiry

2. ACKSDG078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKSDG078 route product structure diagram
    ACKSDG0781126602-45-6
Inquiry

Comments (0)